Heme oxygenase-1 and neurodegeneration: Expanding frontiers of engagement

Journal of Neurochemistry

Volumn 110, Issue 2, 2009, Pages 469-485

  Schipper, Hyman M ^a,b   Song, Wei ^a   Zukor, Hillel ^a   Hascalovici, Jacob R ^a   Zeligman, David ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Aging; Alzheimer disease; Heme oxygenase 1; Iron; Oxidative stress; Parkinson disease

Indexed keywords

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; COMPLEMENTARY DNA; HEME OXYGENASE 1; IRON; MESSENGER RNA;

AGING; ALZHEIMER DISEASE; ASTROCYTE; AUTOPHAGY; BRAIN CONTUSION; BRAIN CORTEX; BRAIN HEMORRHAGE; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; GENE; GENE OVEREXPRESSION; HIPPOCAMPUS; HMOX1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MICROENVIRONMENT; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SENILE PLAQUE; STEROL METABOLISM;

ANIMALS; HEME OXYGENASE-1; HUMANS; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 67649628772     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06160.x     Document Type: Review

References (187)

1. Abraham N. G. Kappas A. (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60, 79 127.
2. Ahmad A. S., Zhuang H. Dore S. (2006) Heme oxygenase-1 protects brain from acute excitotoxicity. Neuroscience 141, 1703 1708. (Pubitemid 44236264)
3. Ali S. F., David S. N. Newport G. D. (1993) Age-related susceptibility to MPTP-induced neurotoxicity in mice. Neurotoxicology 14, 29 34. (Pubitemid 23195761)
4. Anthony S. G., Schipper H. M., Tavares R., Hovanesian V., Cortez S. C., Stopa E. G. Johanson C. E. (2003) Stress protein expression in the Alzheimer-diseased choroid plexus. J. Alzheimers Dis. 5, 171 177. (Pubitemid 37279548)
5. Aschner M. (2000) Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels. Neurotoxicology 21, 1101 1107. (Pubitemid 32172160)
6. Baranano D. E. Snyder S. H. (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc. Natl Acad. Sci. USA 98, 10996 11002. (Pubitemid 32928673)
7. Beal M. (1995) Mitochondrial Dysfunction and Oxidative Damage in Neurodegenerative Diseases. R.G. Landes Co., Austin, TX.
8. Beal M. F. (1996) Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6, 661 666. (Pubitemid 26387722)
9. Bergeron M., Ferriero D. M. Sharp F. R. (1998) Developmental expression of heme oxygenase-1 (HSP32) in rat brain: an immunocytochemical study. Brain Res. Dev. Brain Res. 105, 181 194. (Pubitemid 28153427)
10. Bernardi P. (1996) The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1275, 5 9. (Pubitemid 26233155)
11. Beschorner R., Adjodah D., Schwab J. M., Mittelbronn M., Pedal I., Mattern R., Schluesener H. J. Meyermann R. (2000) Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol. (Berl) 100, 377 384. (Pubitemid 30497006)
12. Bogdanovic N., Bretillon L., Lund E. G., Diczfalusy U., Lannfelt L., Winblad B., Russell D. W. Bjorkhem I. (2001) On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314, 45 48. (Pubitemid 33043802)
13. Brawer J. R. Sonnenschein C. (1975) Cytopathological effects of estradiol on the arcuate nucleus of the female rat. A possible mechanism for pituitary tumorigenesis. Am. J. Anat. 144, 57 88.
14. Brawer J. R., Naftolin F., Martin J. Sonnenschein C. (1978) Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology 103, 501 512. (Pubitemid 8393728)
15. Brawer J. R., Reichard G., Small L. Schipper H. M. (1994a) The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res. 633, 9 20. (Pubitemid 24021238)
16. Brawer J. R., Stein R., Small L., Cisse S. Schipper H. M. (1994b) Composition of Gomori-positive inclusions in astrocytes of the hypothalamic arcuate nucleus. Anat. Rec. 240, 407 415. (Pubitemid 24307261)
17. Businaro R., Fabrizi C., Caronti B., Calderaro C., Fumagalli L. Lauro G. M. (2002) Myelin basic protein induces heme oxygenase-1 in human astroglial cells. Glia 37, 83 88. (Pubitemid 34103097)
18. Butterfield D. A. (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 36, 1307 1313. (Pubitemid 35469517)
19. Calingasan N. Y., Chen J., Kiaei M. Beal M. F. (2005) Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol. Dis. 19, 340 347. (Pubitemid 40544750)
20. Calne D. B. (1994) Neurodegenerative Diseases. W.B. Saunders Co., Philadelphia, PA.
21. Cantuti-Castelvetri I., Shukitt-Hale B. Joseph J. A. (2003) Dopamine neurotoxicity: age-dependent behavioral and histological effects. Neurobiol. Aging 24, 697 706. (Pubitemid 37288868)
22. Castellani R., Smith M. A., Richey P. L., Kalaria R., Gambetti P. Perry G. (1995) Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res. 696, 268 271.
23. Castellani R., Smith M. A., Richey P. L. Perry G. (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737, 195 200. (Pubitemid 26366614)
24. Cavanagh J. B. (1999) Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Brain Res. Rev. 29, 265 295. (Pubitemid 29191343)
25. Chang L., Cornford M., Miller B. L., Itabashi H. Mena I. (1995) Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease. Dementia 6, 1 8.
26. Chen K., Gunter K. Maines M. D. (2000) Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 75, 304 313. (Pubitemid 30418197)
27. Chen-Roetling J., Benvenisti-Zarom L. Regan R. F. (2005) Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury. J. Neurosci. Res. 82, 802 810. (Pubitemid 41746493)
28. Chopra V. S., Moozar K. L., Mehindate K. Schipper H. M. (1997) A cellular stress model for the differential expression of glial lysosomal cathepsins in the aging nervous system. Exp. Neurol. 147, 221 228. (Pubitemid 27497284)
29. Ciechanover A. Brundin P. (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427 446. (Pubitemid 37244106)
30. Cisse S. Schipper H. M. (1995) Experimental induction of corpora amylacea-like inclusions in rat astroglia. Neuropathol. Appl. Neurobiol. 21, 423 431.
31. Connor J. R. (1997) Metals and Oxidative Damage in Neurological Disorders. Plenum Press, New York.
32. Converso D. P., Taille C., Carreras M. C., Jaitovich A., Poderoso J. J. Boczkowski J. (2006) HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J. 20, 1236 1238.
33. Delisle M. B., Uro-Coste E., Murrell J. R., Rascol O. Ghetti B. (2000) Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein. Bull. Acad. Natl Med. 184, 799 809 discussion 809-711.
34. Dennery P. A. (2000) Regulation and role of heme oxygenase in oxidative injury. Curr. Top. Cell. Regul. 36, 181 199.
35. Desmard M., Boczkowski J., Poderoso J. Motterlini R. (2007) Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. Antioxid. Redox Signal. 9, 2139 2155. (Pubitemid 350059023)
36. Desole M. S., Esposito G., Migheli R., Fresu L., Sircana S., Zangani D., Miele M. Miele E. (1995) Cellular defence mechanisms in the striatum of young and aged rats subchronically exposed to manganese. Neuropharmacology 34, 289 295.
37. Di Monte D. A., Schipper H. M., Hetts S. Langston J. W. (1995) Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures. Glia 15, 203 206.
38. Dore S., Takahashi M., Ferris C. D., Zakhary R., Hester L. D., Guastella D. Snyder S. H. (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci. USA 96, 2445 2450. (Pubitemid 29117935)
39. Droge W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47 95. (Pubitemid 34654215)
40. Drummond G. S. Kappas A. (2004) Chemoprevention of severe neonatal hyperbilirubinemia. Semin. Perinatol. 28, 365 368. (Pubitemid 39626119)
41. Durante W. (2003) Heme oxygenase-1 in growth control and its clinical application to vascular disease. J. Cell. Physiol. 195, 373 382. (Pubitemid 36529865)
42. Dwyer B. E., Nishimura R. N., De Vellis J. Yoshida T. (1992) Heme oxygenase is a heat shock protein and PEST protein in rat astroglial cells. Glia 5, 300 305.
43. Dwyer B. E., Nishimura R. N. Lu S. Y. (1995a) Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res. Mol. Brain Res. 30, 37 47.
44. Dwyer B. E., Nishimura R. N. Lu S. Y. (1995b) Differential localization of heme oxygenase and NADPH-diaphorase in spinal cord neurons. Neuroreport 6, 973 976.
45. Exner M., Minar E., Wagner O. Schillinger M. (2004) The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic. Biol. Med. 37, 1097 1104. (Pubitemid 39296737)
46. Finkel T. Holbrook N. J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239 247. (Pubitemid 30839429)
47. Frankel D. Schipper H. M. (1999) Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury. Exp. Neurol. 160, 376 385.
48. Frankel D., Mehindate K. Schipper H. M. (2000) Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J. Cell. Physiol. 185, 80 86.
49. Fukuda K., Richmon J. D., Sato M., Sharp F. R., Panter S. S. Noble L. J. (1996) Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury. Brain Res. 736, 68 75. (Pubitemid 26358000)
50. Galbraith R. (1999) Heme oxygenase: who needs it? Proc. Soc. Exp. Biol. Med. 222, 299 305.
51. Gennuso F., Fernetti C., Tirolo C. et al. (2004) Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). Proc. Natl Acad. Sci. USA 101, 2470 2475. (Pubitemid 38269335)
52. Gollin P. A., Kalaria R. N., Eikelenboom P., Rozemuller A. Perry G. (1992) Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. Neuroreport 3, 201 203.
53. Ham D. Schipper H. M. (2000) Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cell. Mol. Biol. (Noisy-le-grand) 46, 587 596.
54. Hascalovici J. R., Vaya J., Khatib S., Holcroft C., Zukor H. Y., Song W., Arvanatakis Z., Bennett D. Schipper H. M. (2008) A model for sterol dys-regulation in AD brain. Alzheimers Demen. 4 (Suppl. 1 T718.
55. Hascalovici J. R., Song W., Vaya J., Khatib S., Fuhrman B., Aviram M. Schipper H. M. (2009) Impact of heme oxygenase-1 on cholesterol synthesis, cholesterol efflux and oxysterol formation in cultured astroglia. J. Neurochem. 108, 72 81.
56. Hekimi S. Guarente L. (2003) Genetics and the specificity of the aging process. Science 299, 1351 1354. (Pubitemid 36254640)
57. Hirose W., Ikematsu K. Tsuda R. (2003) Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg. Med. (Tokyo) 5 (Suppl. S360 S366.
58. Huang E., Ong W. Y., Go M. L. Garey L. J. (2005) Heme oxygenase-1 activity after excitotoxic injury: immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase inhibition on neuronal survival after kainate treatment. J. Neurosci. Res. 80, 268 278. (Pubitemid 40676310)
59. Hung S. Y., Liou H. C., Kang K. H., Wu R. M., Wen C. C. Fu W. M. (2008) Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol. Pharmacol. 74, 1564 1575.
60. Jarvis M. F. Wagner G. C. (1990) 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity in the rat: characterization and age-dependent effects. Synapse 5, 104 112. (Pubitemid 20095101)
61. Jofre-Monseny L., Loboda A., Wagner A. E., Huebbe P., Boesch-Saadatmandi C., Jozkowicz A., Minihane A. M., Dulak J. Rimbach G. (2007) Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem. iophys. Res. Commun. 357, 319 324. (Pubitemid 46574533)
62. Jozkowicz A., Was H. Dulak J. (2007) Heme oxygenase-1 in tumors: is it a false friend? Antioxid. Redox Signal. 9, 2099 2117. (Pubitemid 350059009)
63. Jurevics H. Morell P. (1995) Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64, 895 901.
64. Kadoya C., Domino E. F., Yang G. Y., Stern J. D. Betz A. L. (1995) Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke 26, 1035 1038.
65. Kappas A., Drummond G. S. Galbraith R. A. (1993) Prolonged clinical use of a heme oxygenase inhibitor: hematological evidence for an inducible but reversible iron-deficiency state. Pediatrics 91, 537 539. (Pubitemid 23065394)
66. Kim H. P., Wang X., Galbiati F., Ryter S. W. Choi A. M. (2004) Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 18, 1080 1089. (Pubitemid 38859216)
67. Kimpara T., Takeda A., Watanabe K. et al. (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum. Genet. 100, 145 147. (Pubitemid 27309669)
68. Kinobe R. T., Vlahakis J. Z., Vreman H. J., Stevenson D. K., Brien J. F., Szarek W. A. Nakatsu K. (2006) Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms. Br. J. Pharmacol. 147, 307 315. (Pubitemid 43214688)
69. Kirkwood T. B. Rose M. R. (1991) Evolution of senescence: late survival sacrificed for reproduction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 332, 15 24.
70. Kitamuro T., Takahashi K., Ogawa K. et al. (2003) Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J. Biol. Chem. 278, 9125 9133. (Pubitemid 36800393)
71. Koeppen A. Dickson A. (1999) Neuroprotection in intracerebral hemorrhage with tin-protoporphyrin. Ann. Neurol. 46, 938.
72. Kowalska A., Danker-Hopfe H., Wender M., Florczak J. Walter H. (1996) Association between the PI*M3 allele of alpha 1-antitrypsin and Alzheimer's disease? A preliminary report. Hum. Genet. 98, 744 746. (Pubitemid 26387969)
73. Kruger R., Kuhn W., Muller T. et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106 108.
74. Kumar P., Wu H., McBride J. L., Jung K. E., Kim M. H., Davidson B. L., Lee S. K., Shankar P. Manjunath N. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448, 39 43. (Pubitemid 47037001)
75. Lavrovsky Y., Drummond G. S. Abraham N. G. (1996) Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements. Biochem. Biophys. Res. Commun. 218, 759 765. (Pubitemid 26050736)
76. Le W. D., Xie W. J. Appel S. H. (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci. Res. 56, 652 658. (Pubitemid 29246847)
77. Lee V. M., Goedert M. Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121 1159. (Pubitemid 32695256)
78. Lee D. W., Gelein R. M. Opanashuk L. A. (2006) Heme-oxygenase-1 promotes polychlorinated biphenyl mixture aroclor 1254-induced oxidative stress and dopaminergic cell injury. Toxicol. Sci. 90, 159 167. (Pubitemid 43264736)
79. Levine S. M. Chakrabarty A. (2004) The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci. 1012, 252 266. (Pubitemid 38453530)
80. Lewis J., McGowan E., Rockwood J. et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402 405. (Pubitemid 32983430)
81. Li Volti G., Ientile R., Abraham N. G. et al. (2004) Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell cultures during differentiation: effect of glutamate. Biochem. Biophys. Res. Commun. 315, 517 524. (Pubitemid 38183136)
82. Lin Q., Weis S., Yang G. et al. (2007a) Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 282, 20621 20633. (Pubitemid 47100046)
83. Lin Y., Vreman H. J., Wong R. J., Tjoa T., Yamauchi T. Noble-Haeusslein L. J. (2007b) Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord. J. Cereb. Blood Flow Metab. 27, 1010 1021. (Pubitemid 46659032)
84. Lin Q. S., Weis S., Yang G., Zhuang T., Abate A. Dennery P. A. (2008) Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress. Free Radic. Biol. Med. 44, 847 855.
85. Llesuy S. F. Tomaro M. L. (1994) Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim. Biophys. Acta 1223, 9 14. (Pubitemid 24262847)
86. Loboda A., Jazwa A., Grochot-Przeczek A., Rutkowski A. J., Cisowski J., Agarwal A., Jozkowicz A. Dulak J. (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 10, 1767 1812.
87. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C. Kalman B. (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177, 95 103. (Pubitemid 30687389)
88. Maes O. C., Kravitz S., Mawal Y. et al. (2006) Characterization of alpha(1)-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol. Dis. 24, 89 100. (Pubitemid 44430147)
89. Maines M. D., Polevoda B., Coban T., Johnson K., Stoliar S., Huang T. J., Panahian N., Cory-Slechta D. A. McCoubrey W. K. Jr. (1998) Neuronal overexpression of heme oxygenase-1 correlates with an attenuated exploratory behavior and causes an increase in neuronal NADPH diaphorase staining. J. Neurochem. 70, 2057 2069. (Pubitemid 28207830)
90. Manganaro F., Chopra V. S., Mydlarski M. B., Bernatchez G. Schipper H. M. (1995) Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain. Free Radic. Biol. Med. 19, 823 835.
91. Mann D. H. A. (1994) Vulnerability of specific neurons to aging, in Neurodegenerative Diseases (Calne D. B., ed pp. 15 31. Saunders, Philadelphia, PA.
92. Mattson M. P. (2002) Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease. Int. Rev. Neurobiol. 53, 387 409.
93. Matz P., Turner C., Weinstein P. R., Massa S. M., Panter S. S. Sharp F. R. (1996) Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res. 713, 211 222. (Pubitemid 26114842)
94. McGeer P. L. McGeer E. G. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21, 195 218. (Pubitemid 26061873)
95. McLaren J., Brawer J. R. Schipper H. M. (1992) Iron content correlates with peroxidase activity in cysteamine-induced astroglial organelles. J. Histochem. Cytochem. 40, 1887 1897.
96. McNaught K. S. Olanow C. W. (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. Ann. Neurol. 53 (Suppl. 3 S73 S84 discussion S84-76.
97. McNaught K. S., Belizaire R., Isacson O., Jenner P. Olanow C. W. (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38 46. (Pubitemid 36062617)
98. Mehindate K., Sahlas D. J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S. Schipper H. M. (2001) Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 77, 1386 1395. (Pubitemid 32523691)
99. Morgan D., Holcomb L., Saad I., Gordon M. Mahin M. (1998) Impaired spatial navigation learning in transgenic mice over-expressing heme oxygenase-1. Brain Res. 808, 110 112. (Pubitemid 29003207)
100. Mydlarski M. B., Liang J. J. Schipper H. M. (1993) Role of the cellular stress response in the biogenesis of cysteamine-induced astrocytic inclusions in primary culture. J. Neurochem. 61, 1755 1765.
101. Mydlarski M., Deschenes J. Schipper H. (2003) Expression of heme oxygenase-1 in the human eye, in Assoc Res Vis Ophthalmo (ARVO). Invest Ophthalmol Vis Sci 44, pp. E-Abstract 649, Ft. Lauderdale.
102. Nakagami T., Toyomura K., Kinoshita T. Morisawa S. (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta 1158, 189 193.
103. Nakaso K., Kitayama M., Fukuda H., Kimura K., Yanagawa T., Ishii T., Nakashima K. Yamada K. (2000) Oxidative stress-related proteins A170 and heme oxygenase-1 are differently induced in the rat cerebellum under kainate-mediated excitotoxicity. Neurosci. Lett. 282, 57 60. (Pubitemid 30129168)
104. Ogawa K. (2002) Heme metabolism in stress response. Nippon Eiseigaku Zasshi 56, 615 621.
105. Otterbein L. E., Soares M. P., Yamashita K. Bach F. H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449 455. (Pubitemid 36928103)
106. Panahian N., Yoshiura M. Maines M. D. (1999) Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem. 72, 1187 1203. (Pubitemid 29085035)
107. Panizzon K. L., Dwyer B. E., Nishimura R. N. Wallis R. A. (1996) Neuroprotection against CA1 injury with metalloporphyrins. Neuroreport 7, 662 666. (Pubitemid 26106190)
108. Perry G., Castellani R. J., Smith M. A. et al. (2003) Oxidative damage in the olfactory system in Alzheimer's disease. Acta Neuropathol. (Berl) 106, 552 556. (Pubitemid 37441611)
109. Petronilli V., Cola C., Massari S., Colonna R. Bernardi P. (1993) Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J. Biol. Chem. 268, 21939 21945.
110. Pfrieger F. W. (2003) Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? BioEssays 25, 72 78. (Pubitemid 36093328)
111. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047. (Pubitemid 27443610)
112. Premkumar D. R., Smith M. A., Richey P. L., Petersen R. B., Castellani R., Kutty R. K., Wiggert B., Perry G. Kalaria R. N. (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J. Neurochem. 65, 1399 1402.
113. Qato M. K. Maines M. D. (1985) Prevention of neonatal hyperbilirubinaemia in non-human primates by Zn-protoporphyrin. Biochem. J. 226, 51 57. (Pubitemid 15127912)
114. Refolo L. M., Pappolla M. A., LaFrancois J. et al. (2001) A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8, 890 899. (Pubitemid 33055603)
115. Reichmann H. Riederer P. (1994) Mitochondrial Disturbances in Neurodegeneration: Neurodegenerative Diseases. Saunders, Philadelphia, PA.
116. Rieder C. R., Williams A. C. Ramsden D. B. (2004) Selegiline increases heme oxygenase-1 expression and the cytotoxicity produced by dopamine treatment of neuroblastoma SK-N-SH cells. Braz. J. Med. Biol. Res. 37, 1055 1062. (Pubitemid 39029126)
117. Rizzu P., Joosse M., Ravid R., Hoogeveen A., Kamphorst W., van Swieten J. C., Willemsen R. Heutink P. (2000) Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients. Hum. Mol. Genet. 9, 3075 3082. (Pubitemid 32000781)
118. Rozema D. B., Lewis D. L., Wakefield D. H. et al. (2007) Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl Acad. Sci. USA 104, 12982 12987. (Pubitemid 351737577)
119. Rubinsztein D. C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780 786. (Pubitemid 44622682)
120. Ryter S. W. Tyrrell R. M. (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic. Biol. Med. 28, 289 309. (Pubitemid 30084022)
121. Sahlas D. J., Liberman A. Schipper H. M. (2002) Role of heme oxygenase-1 in the biogenesis of corpora amylacea. Biogerontology 3, 223 231. (Pubitemid 34884766)
122. Saunders A. M., Strittmatter W. J., Schmechel D. et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467 1472. (Pubitemid 23230526)
123. Sayre L. M., Smith M. A. Perry G. (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem, 8, 721 738. (Pubitemid 32427903)
124. Scapagnini G., D'Agata V., Calabrese V., Pascale A., Colombrita C., Alkon D. Cavallaro S. (2002) Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res. 954, 51 59. (Pubitemid 35223440)
125. Schipper H. M. (1996) Astrocytes, brain aging, and neurodegeneration. Neurobiol. Aging 17, 467 480. (Pubitemid 26201359)
126. Schipper H. M. (1998a) Experimental induction of corpora amylacea in adult rat brain. Microsc. Res. Tech. 43, 43 48. (Pubitemid 28507012)
127. Schipper H. M. (1998b) Glial Iron Sequestration and Neurodegeneration, in Astrocytes in Brain Aging and Neurodegeneration (Schipper H. M., ed pp. 235 251. R.G. Landes Co., Austin, TX.
128. Schipper H. M. (1999) Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. Neurotox. Res. 1, 57 70.
129. Schipper H. M. (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp. Gerontol. 35, 821 830. (Pubitemid 30798080)
130. Schipper H. M. (2001) Mitochondrial iron deposition in aging astroglia: mechanisms and disease implications, in Mitochondrial Ubiquinone (Coenzyme Q): Biochemical, Functional, Medical, and Therapeutic Aspects in Human Health and Disease (Ebadi M. Chopra R. K., eds pp. 267 280. Prominent Press, Scottsdale, AZ.
131. Schipper H. M. (2004a) Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res. Rev. 3, 265 301. (Pubitemid 38844696)
132. Schipper H. M. (2004b) Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress, in Redox-Active Metals in Neurological Disorders (LeVine S., Connor J. R. Schipper H. M., eds 1012, pp. 84 93, Ann NY Acad Sci 1012, New York. (Pubitemid 38453517)
133. Schipper H. M. (2004c) Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 37, 1995 2011. (Pubitemid 39491319)
134. Schipper H. M. (2007) Biomarker potential of heme oxygenase-1 in Alzheimer disease and mild cognitive impairment. Biomarkers Med. 1, 375 385.
135. Schipper H. M. Cissé S. (1995) Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia 14, 55 64.
136. Schipper H., Brawer J. R., Nelson J. F., Felicio L. S. Finch C. E. (1981) Role of the gonads in the histologic aging of the hypothalamic arcuate nucleus. Biol. Reprod. 25, 413 419. (Pubitemid 11029405)
137. Schipper H. M., Scarborough D. E., Lechan R. M. Reichlin S. (1990) Gomori-positive astrocytes in primary culture: effects of in vitro age and cysteamine exposure. Brain Res. Dev. Brain Res. 54, 71 79. (Pubitemid 20177652)
138. Schipper H. M., Kotake Y. Janzen E. G. (1991) Catechol oxidation by peroxidase-positive astrocytes in primary culture: an electron spin resonance study. J. Neurosci. 11, 2170 2176.
139. Schipper H. M., Mydlarski M. B. Wang X. (1993) Cysteamine gliopathy in situ: a cellular stress model for the biogenesis of astrocytic inclusions. J. Neuropathol. Exp. Neurol. 52, 399 410. (Pubitemid 23199200)
140. Schipper H. M., Cisse S. Stopa E. G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37, 758 768.
141. Schipper H. M., Liberman A. Stopa E. G. (1998a) Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp. Neurol. 150, 60 68. (Pubitemid 28146424)
142. Schipper H. M., Vininsky R., Brull R., Small L. Brawer J. R. (1998b) Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra. Exp. Neurol. 152, 188 196. (Pubitemid 28419255)
143. Schipper H. M., Bernier L., Mehindate K. Frankel D. (1999) Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. J. Neurochem. 72, 1802 1811. (Pubitemid 29185982)
144. Schipper H. M., Chertkow H., Mehindate K., Frankel D., Melmed C. Bergman H. (2000) Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54, 1297 1304. (Pubitemid 30174050)
145. Schipper H. M., Mawal Y., Chertkow H. Bergman H. (2001) Blood HO-1 mRNA in AD and MCI. Neurology 57, 2142 2143. (Pubitemid 33126895)
146. Schipper H. M., Bennett D. A., Liberman A., Bienias J. L., Schneider J. A., Kelly J. Arvanitakis Z. (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol. Aging 27, 252 261. (Pubitemid 43038549)
147. Schipper H. M., Gupta A. Szarek W. A. (2009) Suppression of glial HO-1 activitiy as a potential neurotherapeutic intervention in AD. Curr. Alzheimer Res., in press.
148. Selkoe D. J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487 498.
149. Shastry B. S. (2003) Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43, 1 7. (Pubitemid 36246521)
150. Shibata N., Ohnuma T., Baba H. Arai H. (2009) No genetic association between polymorphisms of heme oxygenase 1 and 2 and Alzheimer's disease in a Japanese population. Dement. Geriatr. Cogn. Disord. 27, 273 277.
151. Shobab L. A., Hsiung G. Y. Feldman H. H. (2005) Cholesterol in Alzheimer's disease. Lancet Neurol. 4, 841 852. (Pubitemid 41619439)
152. Smith M. A., Kutty R. K., Richey P. L., Yan S. D., Stern D., Chader G. J., Wiggert B., Petersen R. B. Perry G. (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145, 42 47. (Pubitemid 24217481)
153. Snyder S. H., Jaffrey S. R. Zakhary R. (1998) Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res. Brain Res. Rev. 26, 167 175. (Pubitemid 28318073)
154. Sohal R. S., Mockett R. J. Orr W. C. (2002) Mechanisms of aging: an appraisal of the oxidative stress hypothesis. Free Radic. Biol. Med. 33, 575 586. (Pubitemid 35245829)
155. Song W., Su H., Song S., Paudel H. K. Schipper H. M. (2006) Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J. Cell. Physiol. 206, 655 663. (Pubitemid 43191040)
156. Song L., Song W. Schipper H. M. (2007) Astroglia overexpressing heme oxygenase-1 predispose co-cultured PC12 cells to oxidative injury. J. Neurosci. Res. 85, 2186 2195. (Pubitemid 47172150)
157. Song W., Patel A., Qureshi H. Y., Han D., Schipper H. M. Paudel H. K. (2009) The Parkinson disease-specific A30P mutation stabilizes alpha-synuclein against proteosomal degradation triggered by heme oxygenase 1 overexpression in human neuroblastoma cells. J. Neurochem., in press.
158. Srebro Z. (1971) Periventricular Gomori-positive glia in brains of X-irradiated rats. Brain Res. 35, 463 468.
159. Stahnke T., Stadelmann C., Netzler A., Bruck W. Richter-Landsberg C. (2007) Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J. Mol. Neurosci. 32, 25 37. (Pubitemid 47450554)
160. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N. Ames B. N. (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235, 1043 1046. (Pubitemid 17049750)
161. Stokes A. H., Hastings T. G. Vrana K. E. (1999) Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55, 659 665. (Pubitemid 29173480)
162. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S. Roses A. D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 1977 1981.
163. Sun J., Hoshino H., Takaku K. et al. (2002) Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 21, 5216 5224.
164. Suttner D. M. Dennery P. A. (1999) Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 13, 1800 1809. (Pubitemid 29473342)
165. Suzuki H., Kanamaru K., Tsunoda H., Inada H., Kuroki M., Sun H., Waga S. Tanaka T. (1999) Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J. Clin. Invest. 104, 59 66. (Pubitemid 29534345)
166. Suzuki H., Tashiro S., Sun J., Doi H., Satomi S. Igarashi K. (2003) Cadmium induces nuclear export of Bach1, a transcriptional repressor of heme oxygenase-1 gene. J. Biol. Chem. 278, 49246 49253.
167. Syapin P. J. (2008) Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 155, 623 640.
168. Takahashi M., Dore S., Ferris C. D. et al. (2000) Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28, 461 473.
169. Takeda A., Perry G., Abraham N. G., Dwyer B. E., Kutty R. K., Laitinen J. T., Petersen R. B. Smith M. A. (2000) Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J. Biol. Chem. 275, 5395 5399. (Pubitemid 30115170)
170. Tanaka T., Nishimura Y., Tsunoda H. Naka M. (2000) Pharmacogenomics and therapeutic target validation in cerebral vasospasm. J. Cardiovasc. Pharmacol. 36 (Suppl. 2 S1 S4.
171. Trakshel G. M., Kutty R. K. Maines M. D. (1988) Resolution of the rat brain heme oxygenase activity: absence of a detectable amount of the inducible form (HO-1). Arch. Biochem. Biophys. 260, 732 739. (Pubitemid 18058319)
172. Trapp B. D. Nave K. A. (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247 269.
173. Vasilev V., Veskov R., Janac B., Rakic L. Stojiljkovic M. (2003) Age-related differences in MK-801- and amphetamine-induced locomotor and stereotypic activities of rats. Neurobiol. Aging 24, 715 723. (Pubitemid 37303990)
174. Vaya J. Schipper H. M. (2007) Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem. 102, 1727 1737. (Pubitemid 47329280)
175. Vaya J., Song W., Khatib S., Geng G. Schipper H. M. (2007) Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radic. Biol. Med. 42, 864 871. (Pubitemid 46274172)
176. Verma A., Hirsch D. J., Glatt C. E., Ronnett G. V. Snyder S. H. (1993) Carbon monoxide: a putative neural messenger. Science 259, 381 384.
177. Vincent S. R., Das S. Maines M. D. (1994) Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience 63, 223 231. (Pubitemid 24333963)
178. Vogelsberg-Ragaglia V., Bruce J., Richter-Landsberg C., Zhang B., Hong M., Trojanowski J. Q. Lee V. M. (2000) Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol. Biol. Cell 11, 4093 4104.
179. Volles M. J. Lansbury P. T. Jr. (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595 4602. (Pubitemid 34275660)
180. Wang J. Dore S. (2007) Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 130, 1643 1652. (Pubitemid 47355932)
181. Wang X., Manganaro F. Schipper H. M. (1995) A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system. J. Neurochem. 64, 1868 1877.
182. Williams G. C. (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398 411.
183. Yan S. D., Chen X., Schmidt A. M. et al. (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl Acad. Sci. USA 91, 7787 7791. (Pubitemid 24238270)
184. Yu H.-L., Chertkow H. M., Bergman H. Schipper H. M. (2003) Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics 3, 2240 2248. (Pubitemid 37414088)
185. Yuan Y., Guo J. Z. Zhou Q. X. (2008) The homeostasis of iron and suppression of HO-1 involved in the protective effects of nimodipine on neurodegeneration induced by aluminum overloading in mice. Eur. J. Pharmacol. 586, 100 105.
186. Zhang J. Piantadosi C. A. (1992) Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J. Clin. Invest. 90, 1193 1199.
187. Zukor H., Song W., Liberman A. et al. (2009) HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J. Neurochem. 109, 776 791.